$1.69 Billion is the total value of BROADWOOD CAPITAL INC's 8 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 14.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STAA | STAAR SURGICAL CO | $855,207,000 | +40.1% | 10,795,348 | 0.0% | 50.73% | +5.7% | |
MNST | MONSTER BEVERAGE CORP NEW | $430,632,000 | +15.3% | 4,656,488 | 0.0% | 25.54% | -13.0% | |
IWM | Sell | ISHARES TRrussell 2000 etf | $197,962,000 | +20.7% | 1,009,700 | -7.8% | 11.74% | -8.9% |
AXON | AXON ENTERPRISE INC | $93,130,000 | +35.1% | 760,062 | 0.0% | 5.52% | +1.9% | |
LCTX | LINEAGE CELL THERAPEUTICS IN | $59,849,000 | +87.9% | 34,005,379 | 0.0% | 3.55% | +41.8% | |
OCX | ONCOCYTE CORP | $35,172,000 | +71.9% | 14,716,204 | 0.0% | 2.09% | +29.6% | |
MNST | New | MONSTER BEVERAGE CORP NEWput | $9,248,000 | – | 100,000 | +100.0% | 0.55% | – |
AGE | AGEX THERAPEUTICS INC | $4,556,000 | +87.6% | 2,997,156 | 0.0% | 0.27% | +41.4% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
ISHARES TR | 33 | Q3 2023 | 14.8% |
ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
BIOTIME INC | 25 | Q2 2019 | 17.8% |
AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-15 |
13F-HR | 2024-02-14 |
4 | 2024-02-08 |
4 | 2024-01-10 |
4 | 2024-01-05 |
4 | 2023-11-30 |
13F-HR | 2023-11-14 |
4 | 2023-11-14 |
4 | 2023-11-09 |
4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.